March 21, 2025 FDA Approves Guselkumab for Crohn’s Disease The FDA has approved guselkumab (TREMFYA®) for moderately to severely active Crohn’s disease, supported by Phase 3 trial data showing clinical and endoscopic superiority over ustekinumab. Conexiant
March 20, 2025 In Case You Missed It: Abstracts on Novel Therapies in Gastrointestinal Cancers The ASCO Post
March 19, 2025 FDA Approves Pembrolizumab for HER2-Positive Gastric or GEJ Cancer Expressing PD-L1 The ASCO Post
March 20, 2025 In Case You Missed It: Abstracts on Novel Therapies in Gastrointestinal Cancers The ASCO Post
March 18, 2025 In Case You Missed It: Abstracts on Novel Therapies in Gastrointestinal Cancers The ASCO Post
March 14, 2025 Experimental Regimen Demonstrates Benefit in BRAF V600E–Mutant Metastatic Colorectal Cancer The ASCO Post
February 15, 2024 Do Patients With Molecular MRD Detected After Colorectal Cancer Surgery Benefit From Adjuvant Chemotherapy? The ASCO Post
January 24, 2024 Study Finds Majority of Patients With Lynch Syndrome Are Not Using Aspirin to Reduce Risk of Colon Cancer The ASCO Post
March 03, 2025 ADA urges Congress to strengthen dental coverage, workforce support in House committee letter ADA News